Bruker Announces Management Promotions and Strong Fourth Quarter 2009 Preliminary Operating Results
February 04 2010 - 3:05PM
Business Wire
Bruker Corporation (NASDAQ: BRKR) this week made certain
management changes effective, and today announces strong
preliminary operating results for its fourth quarter, which ended
on December 31, 2009.
Management Promotions Effective February 2010
As previously announced, effective February 1st, 2010 William
Knight, formerly Bruker’s Chief Financial Officer, became the
Company’s Chief Operating Officer. Mr. Knight was succeeded as
Chief Financial Officer by Brian Monahan, previously the Company’s
Vice President of Finance. In addition, Drs. Werner Maas and Bernd
Gewiese were promoted to Co-Presidents of Bruker’s BioSpin
division, also effective as of February 1st, 2010.
Frank Laukien, President and CEO of Bruker Corporation,
commented: “Bruker is fortunate to have outstanding and strongly
committed management talent within the Company, and we are very
pleased to develop our organization further with such excellent
internal candidates. On behalf of the entire Company, I wish Bill,
Brian, Werner and Bernd much success in continuing to drive Bruker
as a customer-oriented, innovative provider of high-performance
scientific instruments and analytical solutions.”
Fourth Quarter 2009 Preliminary Operating Highlights
Bruker intends to announce its fourth quarter (Q4) of 2009 and
full year 2009 financial results on February 25, 2010. The
Company’s preliminary, unaudited operating results for the fourth
quarter of 2009 have significantly exceeded previous
expectations.
For Q4 of 2009:
- total Bruker revenue is now
estimated to be greater than $355 million (on January 13, 2010, the
Company had estimated Q4 revenue of greater than $340 million)
- the Bruker Scientific
Instruments (BSI) segment expects a GAAP operating margin of
greater than 18%
- the Bruker Energy & Supercon
Technologies (BEST) segment estimates revenue at greater than $20
million, with year-over-year growth greater than 75%, and BEST also
anticipates a reduced operating loss year-over-year
The Company’s fourth quarter 2009 financial highlights provided
above are preliminary and do not present all information necessary
for an understanding of the Company’s 2009 financial position and
results of operations. Moreover, the full year 2009 financial
results are currently being audited by the Company’s independent
registered public accounting firm. The Company’s completion of its
2009 financial statements, and the related audit of these financial
statements, could result in material changes to the preliminary
financial results stated above.
ABOUT BRUKER CORPORATION
Bruker Corporation is a leading provider of high-performance
scientific instruments and solutions for molecular and materials
research, as well as for industrial and applied analysis. For more
information about Bruker Corporation, please visit
www.bruker.com.
CAUTIONARY STATEMENT
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking statements
as that term is defined in the Private Securities Litigation Reform
Act of 1995. Any forward-looking statements contained herein are
based on current expectations, but are subject to risks and
uncertainties, that could cause actual future results to differ
materially from those projected including, but are not limited to,
risks and uncertainties relating to adverse changes in conditions
in the global economy and volatility in the capital markets, the
integration of businesses we have acquired or may acquire in the
future, changing technologies, product development and market
acceptance of our products, the cost and pricing of our products,
manufacturing, competition, dependence on collaborative partners
and key suppliers, capital spending and government funding
policies, changes in governmental regulations, realization of
anticipated benefits from economic stimulus programs, intellectual
property rights, litigation, and exposure to foreign currency
fluctuations and other risk factors discussed from time to time in
our filings with the Securities and Exchange Commission. These and
other factors are identified and described in more detail in our
filings with the SEC, including, without limitation, our recent
Proxy Statements on Schedule 14A, our annual report on Form 10-K
for the year ended December 31, 2008, our most recent quarterly
reports on Form 10-Q and our current reports on Form 8-K. We
expressly disclaim any intent or obligation to update these
forward-looking statements other than as required by law.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024